help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Desai-Yajnik, V.
Right arrow Articles by Morimoto, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Desai-Yajnik, V.
Right arrow Articles by Morimoto, T.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*LIOTHYRONINE

Endocrinology, Vol 136, 629-639, Copyright © 1995 by Endocrine Society

ARTICLES

The effect of thyroid hormone treatment on the gene expression and enzyme activity of rat liver sodium-potassium dependent adenosine triphosphatase

V Desai-Yajnik, J Zeng, K Omori, J Sherman and T Morimoto
Department of Cell Biology, New York University School of Medicine, New York 10016.

The effects of thyroid hormone (T3) treatment on liver Na,K-adenosine triphosphatase (Na,K-ATPase) at the levels of subunit messenger RNA (mRNA), enzymatic activity, and enzyme content were studied in euthyroid rats injected for 5 consecutive days with T3. Northern and slot blot analyses of polyadenylated mRNA revealed that T3 treatment coordinately increases the level of mRNA encoding the alpha 1- and beta 1-subunits, approximately 4- and 3-fold, respectively, above basal levels. To determine whether this increase in the subunit mRNA consequently results in an increase in the synthesis of the enzyme, a modified liver cell fractionation procedure was developed, and the subcellular fractions from control and T3-treated livers were examined biochemically. Western blot analysis and Na,K-ATPase assay demonstrated that T3 treatment resulted in a 2-fold increase in both the amount and activity of the enzyme. Furthermore, the Western blot analysis of endoglycosidase-H-treated membrane fractions revealed an increase in the amount of the precursor beta-subunit in the T3-treated liver rough microsomal fraction, suggesting that an increase in subunit synthesis contributes at least partially to the increase in the rat liver Na,K- ATPase by T3 treatment.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
A. W. C. Kung
Thyrotoxic Periodic Paralysis: A Diagnostic Challenge
J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2490 - 2495.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Zeng, M. Ren, D. Gravotta, C. De Lemos-Chiarandini, M. Lui, H. Erdjument-Bromage, P. Tempst, G. Xu, T. H. Shen, T. Morimoto, et al.
Identification of a putative effector protein for rab11 that participates in transferrin recycling
PNAS, March 16, 1999; 96(6): 2840 - 2845.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. Arystarkhova and K. J. Sweadner
Tissue-specific Expression of the Na,K-ATPase beta 3 Subunit. THE PRESENCE OF beta 3 IN LUNG AND LIVER ADDRESSES THE PROBLEM OF THE MISSING SUBUNIT
J. Biol. Chem., September 5, 1997; 272(36): 22405 - 22408.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society